AKT1 and cancer: Hyperactivation of Akt frequently occurs in human cancers as a result of loss-of-function mutations in PTEN, activation mutations in the genes encoding the catalytic subunits of PI3K, activation mutations in the PH domain of Akt, gene amplification of the Akt and PI3K genes, Ras activation, and activation of growth factor receptors (Figure 1).